The global Transdermal Drug Delivery Systems market size was valued at US$ 14730 million in 2023. With growing demand in downstream market, the Transdermal Drug Delivery Systems is forecast to a readjusted size of US$ 18650 million by 2030 with a CAGR of 3.4% during review period.
The research report highlights the growth potential of the global Transdermal Drug Delivery Systems market. Transdermal Drug Delivery Systems are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Transdermal Drug Delivery Systems. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Transdermal Drug Delivery Systems market.
Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Transdermal Drug Delivery Systems market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Transdermal Drug Delivery Systems market. It may include historical data, market segmentation by Type (e.g., Fentanyl, Nitroglycerin), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Transdermal Drug Delivery Systems market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Transdermal Drug Delivery Systems market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Transdermal Drug Delivery Systems industry. This include advancements in Transdermal Drug Delivery Systems technology, Transdermal Drug Delivery Systems new entrants, Transdermal Drug Delivery Systems new investment, and other innovations that are shaping the future of Transdermal Drug Delivery Systems.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Transdermal Drug Delivery Systems market. It includes factors influencing customer ' purchasing decisions, preferences for Transdermal Drug Delivery Systems product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Transdermal Drug Delivery Systems market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Transdermal Drug Delivery Systems market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Transdermal Drug Delivery Systems market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Transdermal Drug Delivery Systems industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Transdermal Drug Delivery Systems market.
Market Segmentation:
Transdermal Drug Delivery Systems market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Fentanyl
Nitroglycerin
Estradiol
Nicotine
Other
Segmentation by application
OTC
Rx
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Hisamitsu
Mylan
GSK
Novartis
Teve (Actavis)
Johnson & Johnson
Lohmann
Teikoku Seiyaku
Bayer
Novartis
Teve (Actavis)
Qizheng
Endo
Huarun 999
Haw Par
Nichiban
Mentholatum
Laboratoires Genevrier
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Transdermal Drug Delivery Systems Market Size 2019-2030
2.1.2 Transdermal Drug Delivery Systems Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Transdermal Drug Delivery Systems Segment by Type
2.2.1 Fentanyl
2.2.2 Nitroglycerin
2.2.3 Estradiol
2.2.4 Nicotine
2.2.5 Other
2.3 Transdermal Drug Delivery Systems Market Size by Type
2.3.1 Transdermal Drug Delivery Systems Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Transdermal Drug Delivery Systems Market Size Market Share by Type (2019-2024)
2.4 Transdermal Drug Delivery Systems Segment by Application
2.4.1 OTC
2.4.2 Rx
2.5 Transdermal Drug Delivery Systems Market Size by Application
2.5.1 Transdermal Drug Delivery Systems Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Transdermal Drug Delivery Systems Market Size Market Share by Application (2019-2024)
3 Transdermal Drug Delivery Systems Market Size by Player
3.1 Transdermal Drug Delivery Systems Market Size Market Share by Players
3.1.1 Global Transdermal Drug Delivery Systems Revenue by Players (2019-2024)
3.1.2 Global Transdermal Drug Delivery Systems Revenue Market Share by Players (2019-2024)
3.2 Global Transdermal Drug Delivery Systems Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Transdermal Drug Delivery Systems by Regions
4.1 Transdermal Drug Delivery Systems Market Size by Regions (2019-2024)
4.2 Americas Transdermal Drug Delivery Systems Market Size Growth (2019-2024)
4.3 APAC Transdermal Drug Delivery Systems Market Size Growth (2019-2024)
4.4 Europe Transdermal Drug Delivery Systems Market Size Growth (2019-2024)
4.5 Middle East & Africa Transdermal Drug Delivery Systems Market Size Growth (2019-2024)
5 Americas
5.1 Americas Transdermal Drug Delivery Systems Market Size by Country (2019-2024)
5.2 Americas Transdermal Drug Delivery Systems Market Size by Type (2019-2024)
5.3 Americas Transdermal Drug Delivery Systems Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Transdermal Drug Delivery Systems Market Size by Region (2019-2024)
6.2 APAC Transdermal Drug Delivery Systems Market Size by Type (2019-2024)
6.3 APAC Transdermal Drug Delivery Systems Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Transdermal Drug Delivery Systems by Country (2019-2024)
7.2 Europe Transdermal Drug Delivery Systems Market Size by Type (2019-2024)
7.3 Europe Transdermal Drug Delivery Systems Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Transdermal Drug Delivery Systems by Region (2019-2024)
8.2 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Type (2019-2024)
8.3 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Transdermal Drug Delivery Systems Market Forecast
10.1 Global Transdermal Drug Delivery Systems Forecast by Regions (2025-2030)
10.1.1 Global Transdermal Drug Delivery Systems Forecast by Regions (2025-2030)
10.1.2 Americas Transdermal Drug Delivery Systems Forecast
10.1.3 APAC Transdermal Drug Delivery Systems Forecast
10.1.4 Europe Transdermal Drug Delivery Systems Forecast
10.1.5 Middle East & Africa Transdermal Drug Delivery Systems Forecast
10.2 Americas Transdermal Drug Delivery Systems Forecast by Country (2025-2030)
10.2.1 United States Transdermal Drug Delivery Systems Market Forecast
10.2.2 Canada Transdermal Drug Delivery Systems Market Forecast
10.2.3 Mexico Transdermal Drug Delivery Systems Market Forecast
10.2.4 Brazil Transdermal Drug Delivery Systems Market Forecast
10.3 APAC Transdermal Drug Delivery Systems Forecast by Region (2025-2030)
10.3.1 China Transdermal Drug Delivery Systems Market Forecast
10.3.2 Japan Transdermal Drug Delivery Systems Market Forecast
10.3.3 Korea Transdermal Drug Delivery Systems Market Forecast
10.3.4 Southeast Asia Transdermal Drug Delivery Systems Market Forecast
10.3.5 India Transdermal Drug Delivery Systems Market Forecast
10.3.6 Australia Transdermal Drug Delivery Systems Market Forecast
10.4 Europe Transdermal Drug Delivery Systems Forecast by Country (2025-2030)
10.4.1 Germany Transdermal Drug Delivery Systems Market Forecast
10.4.2 France Transdermal Drug Delivery Systems Market Forecast
10.4.3 UK Transdermal Drug Delivery Systems Market Forecast
10.4.4 Italy Transdermal Drug Delivery Systems Market Forecast
10.4.5 Russia Transdermal Drug Delivery Systems Market Forecast
10.5 Middle East & Africa Transdermal Drug Delivery Systems Forecast by Region (2025-2030)
10.5.1 Egypt Transdermal Drug Delivery Systems Market Forecast
10.5.2 South Africa Transdermal Drug Delivery Systems Market Forecast
10.5.3 Israel Transdermal Drug Delivery Systems Market Forecast
10.5.4 Turkey Transdermal Drug Delivery Systems Market Forecast
10.5.5 GCC Countries Transdermal Drug Delivery Systems Market Forecast
10.6 Global Transdermal Drug Delivery Systems Forecast by Type (2025-2030)
10.7 Global Transdermal Drug Delivery Systems Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Hisamitsu
11.1.1 Hisamitsu Company Information
11.1.2 Hisamitsu Transdermal Drug Delivery Systems Product Offered
11.1.3 Hisamitsu Transdermal Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Hisamitsu Main Business Overview
11.1.5 Hisamitsu Latest Developments
11.2 Mylan
11.2.1 Mylan Company Information
11.2.2 Mylan Transdermal Drug Delivery Systems Product Offered
11.2.3 Mylan Transdermal Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Mylan Main Business Overview
11.2.5 Mylan Latest Developments
11.3 GSK
11.3.1 GSK Company Information
11.3.2 GSK Transdermal Drug Delivery Systems Product Offered
11.3.3 GSK Transdermal Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 GSK Main Business Overview
11.3.5 GSK Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Transdermal Drug Delivery Systems Product Offered
11.4.3 Novartis Transdermal Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 Teve (Actavis)
11.5.1 Teve (Actavis) Company Information
11.5.2 Teve (Actavis) Transdermal Drug Delivery Systems Product Offered
11.5.3 Teve (Actavis) Transdermal Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Teve (Actavis) Main Business Overview
11.5.5 Teve (Actavis) Latest Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Information
11.6.2 Johnson & Johnson Transdermal Drug Delivery Systems Product Offered
11.6.3 Johnson & Johnson Transdermal Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Johnson & Johnson Main Business Overview
11.6.5 Johnson & Johnson Latest Developments
11.7 Lohmann
11.7.1 Lohmann Company Information
11.7.2 Lohmann Transdermal Drug Delivery Systems Product Offered
11.7.3 Lohmann Transdermal Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Lohmann Main Business Overview
11.7.5 Lohmann Latest Developments
11.8 Teikoku Seiyaku
11.8.1 Teikoku Seiyaku Company Information
11.8.2 Teikoku Seiyaku Transdermal Drug Delivery Systems Product Offered
11.8.3 Teikoku Seiyaku Transdermal Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Teikoku Seiyaku Main Business Overview
11.8.5 Teikoku Seiyaku Latest Developments
11.9 Bayer
11.9.1 Bayer Company Information
11.9.2 Bayer Transdermal Drug Delivery Systems Product Offered
11.9.3 Bayer Transdermal Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Bayer Main Business Overview
11.9.5 Bayer Latest Developments
11.10 Novartis
11.10.1 Novartis Company Information
11.10.2 Novartis Transdermal Drug Delivery Systems Product Offered
11.10.3 Novartis Transdermal Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Novartis Main Business Overview
11.10.5 Novartis Latest Developments
11.11 Teve (Actavis)
11.11.1 Teve (Actavis) Company Information
11.11.2 Teve (Actavis) Transdermal Drug Delivery Systems Product Offered
11.11.3 Teve (Actavis) Transdermal Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Teve (Actavis) Main Business Overview
11.11.5 Teve (Actavis) Latest Developments
11.12 Qizheng
11.12.1 Qizheng Company Information
11.12.2 Qizheng Transdermal Drug Delivery Systems Product Offered
11.12.3 Qizheng Transdermal Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Qizheng Main Business Overview
11.12.5 Qizheng Latest Developments
11.13 Endo
11.13.1 Endo Company Information
11.13.2 Endo Transdermal Drug Delivery Systems Product Offered
11.13.3 Endo Transdermal Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Endo Main Business Overview
11.13.5 Endo Latest Developments
11.14 Huarun 999
11.14.1 Huarun 999 Company Information
11.14.2 Huarun 999 Transdermal Drug Delivery Systems Product Offered
11.14.3 Huarun 999 Transdermal Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Huarun 999 Main Business Overview
11.14.5 Huarun 999 Latest Developments
11.15 Haw Par
11.15.1 Haw Par Company Information
11.15.2 Haw Par Transdermal Drug Delivery Systems Product Offered
11.15.3 Haw Par Transdermal Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Haw Par Main Business Overview
11.15.5 Haw Par Latest Developments
11.16 Nichiban
11.16.1 Nichiban Company Information
11.16.2 Nichiban Transdermal Drug Delivery Systems Product Offered
11.16.3 Nichiban Transdermal Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Nichiban Main Business Overview
11.16.5 Nichiban Latest Developments
11.17 Mentholatum
11.17.1 Mentholatum Company Information
11.17.2 Mentholatum Transdermal Drug Delivery Systems Product Offered
11.17.3 Mentholatum Transdermal Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Mentholatum Main Business Overview
11.17.5 Mentholatum Latest Developments
11.18 Laboratoires Genevrier
11.18.1 Laboratoires Genevrier Company Information
11.18.2 Laboratoires Genevrier Transdermal Drug Delivery Systems Product Offered
11.18.3 Laboratoires Genevrier Transdermal Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Laboratoires Genevrier Main Business Overview
11.18.5 Laboratoires Genevrier Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
